Golimumab 50 mg every 4 weeks + MTX vs placebo + MTXPhysical function · patients with rheumatoid arthritis1 finding from 1 reviewGolimumab for rheumatoid arthritis 2010 · Cochrane Headline outcomes onlyno estimate extracted1 study · 308 participantsHigh